Heart Test Labs Files Definitive Proxy Statement

TL;DR

Heart Test Labs filed its proxy statement, shareholders vote soon.

AI Summary

Heart Test Laboratories, Inc. filed a DEF 14A on September 18, 2024, for its fiscal year ending April 30, 2024. This filing is a definitive proxy statement, indicating it contains important information for shareholders regarding upcoming meetings or votes. The company is based in Southlake, Texas, and operates in the orthopedic, prosthetic & surgical appliances & supplies industry.

Why It Matters

This filing provides shareholders with crucial information for exercising their voting rights, impacting corporate governance and future company decisions.

Risk Assessment

Risk Level: medium — Proxy statements can signal upcoming corporate actions or shareholder votes that may significantly impact the company's stock price and future direction.

Key Players & Entities

• Heart Test Laboratories, Inc. (company) — Registrant
• 0001213900-24-079949 (filing_id) — Accession Number
• 20240918 (date) — Filing Date
• 20241107 (date) — Period of Report
• 550 RESERVE ST, SUITE 360 (address) — Business Address
• SOUTHLAKE (city) — Business Address City
• TX (state) — Business Address State
• 76092 (zip_code) — Business Address Zip
• 682-237-7781 (phone_number) — Business Phone

FAQ

Key Financial Figures

• $0.001 — r Series C Convertible Preferred Stock, $0.001 par value per share (the “Series

Filing Documents

• ea0214952-01.htm (DEF 14A) — 465KB
• theart_logo.jpg (GRAPHIC) — 47KB
• tproxy_001.jpg (GRAPHIC) — 1122KB
• tproxy_002.jpg (GRAPHIC) — 903KB
• 0001213900-24-079949.txt ( ) — 3322KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS   11 SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE   13 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS   14 PROPOSAL NO. 1 — RATIFICATION OF THE APPOINTMENT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM   18 PROPOSAL NO. 2. — APPROVAL OF AN ADJOURMENT OF THE ANNUAL MEETING TO A LATER DATE OR TIME IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE ANNUAL MEETING   19 REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS   20 PARTICIPANTS IN THE SOLICITATION   21 EXPENSES OF SOLICITATION   21 OTHER INFORMATION   21 i Table of Contents 550 Reserve Street, Suite 360 Southlake, TX 76092 PROXY STATEMENT FOR ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON NOVEMBER 7, 2024 The board of directors of Heart Test Laboratories, Inc., a Texas corporation (“we,” “us,” “our,” HeartSciences” or “our Company”) solicits the enclosed proxy for our Annual Meeting of Shareholders for our fiscal year ended April 30, 2024 (the “Annual Meeting”) to be held virtually via a live audio webcast at https://web.lumiconnect.com/293046675 on Thursday, November 7, 2024, at 9:00 a.m. Eastern Time, and for any adjournment or postponement thereof. This proxy statement (this “Proxy Statement”) is being made available to shareholders on or about September 18, 2024. QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS AND THE ANNUAL MEETING 1.   Q: Why did I receive a notice regarding the availability of proxy materials on the internet? A:  Instead of mailing paper proxy materials, we sent a “Notice of Internet Availability of Proxy Materials” to our shareholders of record. We refer to that

View Full Filing

View this DEF 14A filing on SEC EDGAR